M. Ferracin
Molecular Biology · 2004–2023
A researcher in the Science corpus: 15 papers; trusts 10 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 268 citations into it; #7,039 of 17,773 by trust here, #558 by citations
- Cancer Research — 245 citations into it; #431 of 1,780 by trust here, #48 by citations
- Plant Science — 16 citations into it
Whom M. Ferracin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- George A. Calin
- Chang-Gong Liu
- Frank J. Slack
- Benjamin P. Lewis
- Manel Esteller
- Carlo Maria Croce
- Sam Griffiths-Jones
- W. Du
- Yang Wang
- V. Ambros
Who trusts M. Ferracin overall
- Carlo Maria Croce
- Marilena V. Iorio
- George A. Calin
- John S. Mattick
- Leigh-Ann MacFarlane
- Xing Chen
- Danish H Sayed
- O. Kent
- Joshua T. Mendell
- R. Garzon
Papers from M. Ferracin's perspective
Ordered by how strongly the researchers M. Ferracin trusts endorse each paper. Same corpus, a different order for every researcher.
- A combined computational-experimental approach predicts human microRNA targets. (Genes & Development)
- Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis (Nature)
- Silencing of microRNAs in vivo with ‘antagomirs’ (Nature)
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution (Science)
- A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. (Genes & Development)
- Identification of hundreds of conserved and nonconserved human microRNAs (Nature Genetics)
- A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (Science)
- Expression profiling reveals off-target gene regulation by RNAi
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia (Proceedings of the National Academy of Sciences of the United States of America)
- Accumulation of miR-155 and BIC RNA in human B cell lymphomas. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- miR-15 and miR-16 induce apoptosis by targeting BCL2. (2005) — 3,834 citations
- MicroRNA gene expression deregulation in human breast cancer. (2005) — 4,255 citations
- A microRNA expression signature of human solid tumors defines cancer gene targets (2006) — 6,046 citations
- An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. (2004) — 972 citations
- MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. (2004) — 1,351 citations
- Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. (2007) — 744 citations
- A MicroRNA Signature of Hypoxia (2006) — 1,078 citations
- Extensive modulation of a set of microRNAs in primary glioblastoma. (2005) — 1,168 citations
- CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer (2013) — 620 citations
- MiR-15a and miR-16-1 cluster functions in human leukemia (2008) — 818 citations
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma (2008) — 665 citations
- Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. (2007) — 842 citations
- Micro-RNA profiling in kidney and bladder cancers. (2007) — 645 citations
- Non-coding RNAs in disease: from mechanisms to therapeutics (2023) — 743 citations
- A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. (2005) — 2,531 citations